HLN
Haleon Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$8.57
−14.30%Forward multiples
Based on analyst estimates
- P/E forward
- 18.99x
- P/E 2026E
- 15.26x
- P/E 2027E
- 14.03x
- P/E 2028E
- 12.99x
- P/S forward
- 2.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.86x
- PEG TTM
- 2.11x
- Price / book
- 1.74x
- Price / sales
- 2.56x
- Price / cash flow
- 12.37x
Enterprise value
- Enterprise value
- $47.6B
- EV / sales
- 3.24x
- EV / EBITDA
- 12.40x
- EV / EBIT
- 14.81x
- Market cap
- $37.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026